FibroBiologics (FBLG) Stock Forecast, Price Target & Predictions
FBLG Stock Forecast
FibroBiologics stock forecast is as follows: an average price target of $9.00 (represents a 328.57% upside from FBLG’s last price of $2.10) and a rating consensus of 'Buy', based on 2 wall street analysts offering a 1-year stock forecast.
FBLG Price Target
The average price target for FibroBiologics (FBLG) is $9.00 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $9.00 to $9.00. This represents a potential 328.57% upside from FBLG's last price of $2.10.
FBLG Analyst Ratings
According to 2 Wall Street analysts, FibroBiologics's rating consensus is 'Buy'. The analyst rating breakdown for FBLG stock is 0 'Strong Buy' (0.00%), 2 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
FibroBiologics Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 30, 2024 | Jason Kolbert | EF Hutton | $9.00 | $2.88 | 212.50% | 328.57% |
The latest FibroBiologics stock forecast, released on Oct 30, 2024 by Jason Kolbert from EF Hutton, set a price target of $9.00, which represents a 212.50% increase from the stock price at the time of the forecast ($2.88), and a 328.57% increase from FBLG last price ($2.10).
FibroBiologics Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 1 | 1 |
| Avg Price Target | - | $9.00 | $9.00 |
| Last Closing Price | $2.10 | $2.10 | $2.10 |
| Upside/Downside | -100.00% | 328.57% | 328.57% |
In the current month, the average price target of FibroBiologics stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to FibroBiologics's last price of $2.10. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 30, 2024 | H.C. Wainwright | Buy | Initialise | |
| Sep 04, 2024 | EF Hutton | Buy | Initialise |
FibroBiologics's last stock rating was published by H.C. Wainwright on Oct 30, 2024. The company Initialise its FBLG rating from "null" to "Buy".
FibroBiologics Financial Forecast
FibroBiologics Revenue Forecast
| Revenue |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| # Analysts |
| Surprise % |
FibroBiologics's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. FBLG's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).
FibroBiologics EBITDA Forecast
| # Analysts |
| EBITDA |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
undefined analysts predict FBLG's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than FibroBiologics's previous annual EBITDA (undefined) of $NaN.
FibroBiologics Net Income Forecast
| # Analysts |
| Net Income |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
FibroBiologics's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. FBLG's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
FibroBiologics SG&A Forecast
| # Analysts |
| SG&A |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
FibroBiologics's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to FBLG last annual SG&A of $NaN (undefined).
FibroBiologics EPS Forecast
| # Analysts |
| EPS |
| Avg Forecast |
| High Forecast |
| Low Forecast |
| Surprise % |
According to undefined Wall Street analysts, FibroBiologics's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to FBLG previous annual EPS of $NaN (undefined).